0001104659-24-054950.txt : 20240430
0001104659-24-054950.hdr.sgml : 20240430
20240430161706
ACCESSION NUMBER: 0001104659-24-054950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240429
FILED AS OF DATE: 20240430
DATE AS OF CHANGE: 20240430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHAH MAHENDRA
CENTRAL INDEX KEY: 0001255449
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38067
FILM NUMBER: 24897503
MAIL ADDRESS:
STREET 1: 2250 HOLCOMBE BLVD
CITY: HOUSTON
STATE: TX
ZIP: 77030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verona Pharma plc
CENTRAL INDEX KEY: 0001657312
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
BUSINESS PHONE: 011-44-0-2032834200
MAIL ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
4
1
tm2412993-7_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-04-29
0
0001657312
Verona Pharma plc
VRNA
0001255449
SHAH MAHENDRA
3 MORE LONDON RIVERSIDE
LONDON
X0
SE1 2RE
UNITED KINGDOM
1
0
0
0
0
Share Options (Right to Buy)
1.9338
2024-04-29
4
A
0
240000
0
A
2034-04-28
Ordinary Shares
240000
240000
D
The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer.
The option vests and becomes exercisable as to 25% on each of July 29, 2024, October 29, 2024, January 29, 2025 and April 29, 2025.
/s/ Claire Poll, Attorney-in-fact for Mahendra Shah
2024-04-30